Pfizer assigns Meenakshi Nevati as Managing Director

Meenakshi Nevatia has been appointed by Pfizer Limited as the company's managing director and additional director for a term of five years beginning on April 3, 2023. S.Sridhar, who announced his early retirement in August 2022, is succeeded by...

AstraZeneca profits rise on cancer drugs, Alexion buy

AstraZeneca, a British pharmaceutical firm, reported a record annual net profit, boosted by cancer treatments and the integration of biotech unit Alexion following a blockbuster takeover...

Wellmarker Bio enters clinical trial partnership with MSD to evaluate WM-A1-3389 in combo with Keytruda

Wellmarker Bio Co., Ltd (WMBIO), a predictive biomarker-driven biotech company, has entered a clinical trial collaboration and supply agreement with MSD (Merck & Co., Inc., Rahway, NJ, USA)....

Tecan partners with Element Biosciences to provide benchtop NGS workflow with MagicPrep NGS & AVITI System

With MagicPrep NGS and the AVITI System, Tecan and Element Biosciences, Inc, the developer of an innovative DNA sequencing platform that is disrupting genomics, are collaborating to offer a true benchtop NGS workflow. The collaboration will...

GSK's India unit posts 9% increase in Q3 profit as input costs slump

GlaxoSmithKline Pharmaceuticals Ltd, the Indian unit of UK's GSK plc, reported a 9.5 per cent rise in third-quarter profit, in line with analysts' estimates, as a sharp drop in input costs more than offset a revenue decline.

Actinium enters CRADA with NCI to develop Actimab-A to treat AML and other hematologic malignancies

Actinium Pharmaceuticals, Inc., a pioneer in the development of targeted radiotherapies, announced a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI), a component of the National Institutes of Health...

Addex Therapeutics completes enrollment in ADX71149 epilepsy phase 2 study part 1

Addex Therapeutics, a clinical-stage pharmaceutical company, announced the completion of Part 1 of the phase 2 clinical study of ADX71149 (JNJ-40411813) for the treatment of epilepsy...

Apollo Hospitals launched Clinical Intelligence Engine for doctors across India

The Apollo Hospitals Group, one of Asia's largest and most trusted healthcare providers, has announced the launch of the Apollo Clinical Intelligence Engine, a clinical decision support tool that will be available to all India doctors through the...

Aardex, Cambridge Cognition collaborates to bring next-level adherence oversight to hybrid and decentralized clinical trials

Adherence specialists Aardex Group and remote research platform experts in the Clinpal team at Cambridge Cognition have teamed up to provide next-level adherence monitoring during hybrid and decentralized clinical trials (DCTs)...

Most Impactful Trends in Biotechnology Industry

Biotechnology poses some risks to human health and the environment. These risks must be carefully managed to ensure that the benefits of biotechnology outweigh the risks. Biotechnology poses some risks to human health and the environment

© 2025 India Pharma Outlook. All Rights Reserved.